|
Cut the Cost of Doing Business |
SoCalBio partners with AT Conference to offer member companies the cheapest per-minute -- phone (3.5 cents) and web (8 cents) conferencing rates -- available on the market today ... Learn more |
|
|
Thanks to SoCalBio Weekly Update Sponsor
|
Recommended Events
September 7 - 9
Boston, MA
September 26- 28
Washington DC
October 3-5
Pasadena, CA
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why |
 |
| Thanks to SoCalBio Media Partners
| | |
New Report
|
|
Biotech M&A Activity Jumps in the First Half of 2011
 A new report from private equity group HBM Partners sheds light on the alive-and-well M&A market for venture-backed biotech companies. The report concludes that deal activity during the first half of this year hit its highest mark since the second half of 2006 ... Click here to see a pdf copy of the report
|
Interview
|
|
Manish Singh: Cancer Treatment Revolution Just Beginning
 Read BioMedReports' interview with Manish Singh, PhD, President & CEO, ImmunoCellular Therapeutics (Woodland Hills) on the curent trials and tribulations of Dendreon on Wall Street and the future of immuno therapeutics for cancer ... Click here to access the interview
|
|
Coming This Week |
|
BIO's Chief James Greenwood Meets with SoCalBio Members on August 18 to Discuss BIO's
New 5-Year Plan
 During his first visit to Los Angeles since assuming BIO's leadership position, James Greenwood (photo right), Former Congressman and now President & CEO of the Biotechnology Industry Organization (BIO), will meet with executives representing emerging biotech companies in the Greater Los Angeles/Orange County region to discuss BIO's new policy agenda. This agenda is embodied in a new 5-year plan designed to enable the biotechnology industry to fulfill its promise to help, heal, fuel, and feed the world ... Access BIO's Plan
|
| RSVP Now |
|
SoCalBio Networking Forum in Ventura County
Micro-Manufacturing the
Next-Generation Medical Devices
Thursday, August 25, 2011
4:00 PM - 7:00 PM (PT)
Westlake Village Inn
31943 Agoura Road, Westlake Village, CA 91361
|
|
Coming in November |
|
|
|
Welcome, New SoCalBio Member |
|
Zickfeld Associates (Los Angeles)
Zickfeld Associates is a boutique advisory firm providing the life sciences, medical device, and technology industries with business strategy and business development expertise and advice.
National Green Gas LLC (Indio)
National Green Gas is a new company in Southern California that has a recently approved technology for treating all biomedical waste types without incineration. The process is approved by the State Dept of Public Health and is less expensive, more efficient, and greener and achieves the ultimate goal of landfill diversion ... Read more
Avita Medical (Northridge)
Avita Medical develops spray-on skin processes to treat skin trauma, including burns. The Company markets its skin products under the names CellSpray and ReCell. According to Avita, ReCell has been approved for marketing and sale in Europe, Canada and Australia... Click here for more info
Amicrobe (Pasadena)
Amicrobe, Inc. uses advanced synthetic biopolymer chemistry to create materials that can prevent and treat infections. These materials can be designed to have broad-based antimicrobial activities as well as to support wound healing... Learn more |
 |
 |
HIV
|
|
USC Scientist Develops Virus That Targets HIV
 USC Chemical Engineering professor Pin Wang (photo right) created a lentiviral vector that latches onto HIV-infected cells, flagging them with what is called "suicide gene therapy" - allowing drugs to later target and destroy them ... Read more
|
Inhaled Insulin Trials
|
|
MannKind Confirms Design of Pivotal Studies
 The Valencia-based MannKind Corporation announced that it has confirmed with the U.S. Food and Drug Administration the design of two clinical studies that evaluate the efficacy and safety of AFREZZA, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler. The FDA had previously requested that MannKind conduct two clinical trials with the next-generation inhaler (one in patients with type 1 diabetes and one in patients with type 2 diabetes), with at least one trial including a treatment group using the previously studied MedTone inhaler in order to obtain a head-to-head comparison of the pulmonary safety data for the two devices .... Read more
|
Litigation
|
|
Avanir Sues Generic Drugmakers Over Neudexta
 The Aliso Viejo-based company is suing two generic drugmakers - Par Pharmaceutical Companies Inc. of Woodcliff Lake, N.J., and privately held Actavis Inc. -- over patents protecting its drug Nuedexta, which Avanir started selling earlier this year. Par and Actavis have applied with regulators to sell generic versions of Nuedexta before patents protecting the drug expire... Read more
|
People on the Move
|
|
The Irvine-Based BIOLASE Names Ehab M. Esmail Vice President Global Regulatory, Quality and Clinical Affairs
 Esmail, 39, has more than 18 years of diversified experience working as a specialist in regulatory affairs in the medical device and biologics industries. During that time, he has been proactive in managing product registrations, averaging more than 340 annually over the last five years plus clinical studies and reacting to changes in government regulations as they relate to existing products and the development of new products ... Read more
|
Jobs Available
|
|
Biolase (Irvine)
Radient Pharmaceuticals (Tustin)
Gilead (San Dimas)
Maven Biotech (Pasadena)
IntriMed Technologies (Ventura)
Nanogea (Culver City)
| |
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio | | |
